Hayakawa, K., Ueda, T., Iehara, M., Gabata, Y., Murashita, J., Takahashi, H., Saito, Y., Miyashita, M., Yamada, Y., Shiraishi, T., Fujihara, A., Okumi, M., Hongo, F., Ukimura, O. (2026). Triplet versus doublet therapy in patients with metastatic hormone-sensitive prostate cancer. Scientific Reports. https://doi.org/10.1038/s41598-026-44627-w